Phase 2 Trial of XOMA 052 to be Initiated in Type 1 Diabetes Patients

BERKELEY, Calif., Nov. 4, 2009 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced plans to initiate an investigator sponsored Phase 2 clinical trial... [read full story]                    

powered by
Add Comment
There are also 9 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies